IAIM
SUPN icon

International Assets Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

International Assets Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25
Closed -$1.24K – 2356
2025
Q4 		$1.24K Buy
+25
New +$1.22K ﹤0.01% 2012
2024
Q4 		– Sell
-686
Closed -$22 – 1796
2024
Q3 		$22 Buy
686
+664
+3,018% +$20.7K ﹤0.01% 1763
2024
Q2 		$589 Buy
+22
New +$638 ﹤0.01% 2159
2023
Q2 		– Sell
-22
Closed -$797 – 962
2023
Q1 		$797 Buy
+22
New +$846 ﹤0.01% 1056

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

International Assets Investment Management's SUPN Position: Q1 2026 in Review

International Assets Investment Management sold out of Supernus Pharmaceuticals (SUPN) in Q1 2026, closing a stake of 25 shares — an estimated $1.24K sold.

International Assets Investment Management first reported a position in SUPN in Q1 2023 and held it in 4 quarters. The position peaked at $1.24K in Q4 2025. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • International Assets Investment Management reported no remaining Supernus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • International Assets Investment Management sold 25 Supernus Pharmaceuticals shares in Q1 2026, an estimated $1.24K.
  • International Assets Investment Management first reported a position in Supernus Pharmaceuticals in Q1 2023 and held it in 4 quarters.
  • International Assets Investment Management's Supernus Pharmaceuticals position peaked at $1.24K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on International Assets Investment Management's 13F filing for Q1 2026, filed 1 May 2026.